PRESS RELEASE published on 08/16/2023 at 08:15, 1 year 7 months ago EXASOL AG: Exasol publishes half-year report and confirms preliminary figures
PRESS RELEASE published on 08/08/2023 at 09:34, 1 year 7 months ago Exasol publishes preliminary figures for the first half of 2023, outlook confirmed
PRESS RELEASE published on 06/30/2023 at 09:01, 1 year 9 months ago EXASOL SUCCESSFULLY COMPLETES CAPITAL INCREASE AND GENERATES GROSS PROCEEDS OF 7.1 MILLION EUROS
PRESS RELEASE published on 06/30/2023 at 08:49, 1 year 9 months ago EQS-Adhoc: EXASOL SUCCESSFULLY PLACES 2.4 MILLION NEW SHARES FROM CASH CAPITAL INCREASE WITH GROSS PROCEEDS OF EUR 7.1 MILLION
PRESS RELEASE published on 06/29/2023 at 17:45, 1 year 9 months ago EQS-Adhoc: EXASOL AG: EXASOL LAUNCHES 10% CASH CAPITAL INCREASE, TARGETING GROSS PROCEEDS OF APPROXIMATELY EUR 7 MILLION
PRESS RELEASE published on 05/30/2023 at 11:11, 1 year 10 months ago Exasol Unveils the No-Compromise Analytics Database Unlocking Greater Productivity, Cost-Savings, and Flexibility
PRESS RELEASE published on 05/10/2023 at 08:29, 1 year 10 months ago Exasol publishes audited consolidated financial statements for 2022 and earnings for Q1 2023
PRESS RELEASE published on 04/28/2023 at 08:01, 1 year 11 months ago Exasol announces preliminary figures for first quarter 2023: Operating profit improves - new business in the U.S. market ramps up
PRESS RELEASE published on 02/17/2023 at 13:07, 2 years 1 month ago EXASOL AG: Exasol announces preliminary figures for 2022, outlook for 2023 and need to adjust the 2025 mid-term target
PRESS RELEASE published on 02/17/2023 at 12:51, 2 years 1 month ago EQS-Adhoc: EXASOL AG: Exasol announces preliminary figures for 2022, outlook for 2023 and the need to adjust the 2025 mid-term target
Published on 04/07/2025 at 00:05, 7 hours 32 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 5 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 07:03, 34 minutes ago Swiss Re to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range
Published on 04/07/2025 at 07:00, 37 minutes ago Julius Baer further streamlines its organisation to reinforce focus on clients and sustainable growth
Published on 04/06/2025 at 18:20, 13 hours 17 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 16 hours 28 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 12 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/07/2025 at 07:01, 36 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 36 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 13 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
